We were delighted to talk with Professor Jan Hedner (The University of Gothenburg, Gothenburg, Sweden) around the rationale, and safety and efficacy findings of using sulthiame in moderate to severe obstructive sleep apnoea.
The abstract ‘Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial’ (Presentation ID 4383) was presented at ERS International Congress 2021, 5-8 September 2021.
- What have been the challenges of developing pharmacologic remedies for obstructive sleep apnoea (OSA)? (0:13)
- What is the mechanism of action of sulthiame and what is the rationale for its use in the treatment of OSA? (0:52)
- What were the aims, design and inclusion criteria of your study? (1:46)
- What were the primary and secondary outcome measures, and how well were they met? (2:22)
- What were the conclusions of the investigators, and what future studies are planned? (3:40)
- What are the hot topics and latest research you are looking forward to exploring in OSA during 2021? (4:20)
Disclosures: Jan Hedner is a share holder of IP related to the medication discussed.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of ERS 2021 (Virtual).
Share this Video
Related Videos In Sleep Related Breathing Disorders
Margaret Pisani, CHEST 2022: Highlights and networking opportunities
CHEST 2022 took place between October 16-19 in Nashville, TN, we interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) around her personal congress highlights and the networking opportunities which were available on site. Questions What CHEST presentations had the greatest impact this year and what were your personal […]
John Harsh, CHEST 2022: Long term safety of FT218 in the treatment of narcolepsy
Once-nightly sodium oxybate (FT218) is currently being investigated in the open label phase 3 study RESTORE (NCT04451668) for the treatment of narcolepsy. We caught up with Prof. John Harsh (University of Colorado Boulder, Boulder, CO, USA) to discuss the aims, design, inclusion criteria and interim findings of the RESTORE study. The abstract ‘LONG-TERM SAFETY OF […]
Joerg Steier, ATS 2022: the Delphi Consensus Statements on Excessive Daytime Sleepiness in Obstructive Sleep Apnea
It was a pleasure to talk with Professor Joerg Steier (King’s College London, London, UK) around the development of the Delphi Consensus Statements on the diagnosis and management of excessive daytime sleepiness in obstructive sleep apnea and how these statements will help identify and address the unmet needs. The abstract ‘Development of Delphi Consensus Statements […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!